S. Pay et al., Sulfasalazine-induced Angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis, RHEUM INTL, 20(1), 2000, pp. 25-27
We describe a patient with juvenile chronic arthritis who developed reactiv
e angioimmunoblastic lymphadenopathy, induced by sulfasalazine. Development
of angioimmunoblastic lymphadenopathy although rare, is a very serious sid
e effect of sulfasalazine treatment, and patients treated with this drug sh
ould be watched carefully.